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Abstract
Background: The fibroblast growth factor receptor (FGFR) interprets concentration gradients of FGF ligands and 
structural changes in the heparan sulfate (HS) co-receptor to generate different cellular responses. However, whether 
the FGFR generates different signals is not known.
Results: We have previously shown in rat mammary fibroblasts that in cells deficient in sulfation, and so in HS co-
receptor, FGF-2 can only stimulate a transient phosphorylation of p42/44MAPK and so cannot stimulate DNA synthesis. 
Here we demonstrate that this is because in the absence of HS, FGF-2 fails to stimulate the phosphorylation of the 
adaptor FGFR substrate 2 (FRS2). In cells possessing the HS co-receptor, FGF-2 elicits a bell-shaped dose response: 
optimal concentrations stimulate DNA synthesis, but supramaximal concentrations (≥ 100 ng/mL) have little effect. At 
optimal concentrations (300 pg/mL) FGF-2 stimulates a sustained dual phosphorylation of p42/44MAPK and tyrosine 
phosphorylation of FRS2. In contrast, 100 ng/mL FGF-2 only stimulates a transient early peak of p42/44MAPK 
phosphorylation and fails to stimulate appreciably the phosphorylation of FRS2 on tyrosine.
Conclusions: These results suggest that the nature of the FGFR signal produced is determined by a combination of the 
HS co-receptor and the concentration of FGF ligand. Both the phosphorylation of the adaptor FRS2, the kinetics 
(sustained or transient) of phosphorylation of p42/44(MAPK) are varied, and so differing cellular responses are 
produced.
Background
Fibroblast growth factors (FGFs) constitute a family of
structurally related proteins, which regulate many facets
of cell behaviour, from embryonic patterning, to tissue
repair and metabolism [1-3]. FGFs exert their effects on
cells by interacting with a signalling receptor tyrosine
kinase (FGFR) and a glycosaminoglycan co-receptor, usu-
ally heparan sulfate (HS) [4]. Assembly of the complex of
FGF ligand, HS and FGFR leads to activation of the intra-
cellular kinase of the receptor through autophosphoryla-
tion of two tyrosines in its activation loop, which results
in the phosphorylation of other tyrosine residues in the
intracellular domain of the receptor that serve as docking
sites for SH2 and PTB domain containing proteins [1,5,6].
These include growth factor receptor binder-2 (GRB2)
and FGFR substrate 2 (FRS2). FRS2 is a lipid-anchored
docking protein, which serves as a major intracellular
substrate of the FGFR kinase. Unlike GRB2, which binds
via phosphotyrosines [7,8], FRS2 binds to the juxtamem-
brane region of FGFR via its phosphotyrosine-binding
(PTB) domain independently of tyrosine phosphorylation
[9]. Upon FGF stimulation, FRS2 is rapidly and highly
phosphorylated on multiple tyrosine residues, four of
which function as docking sites for the SRC homology2
(SH2) domain of GRB2 [10] and two as binding sites for
the N-terminal SH2 domain of the SH2-containing pro-
tein tyrosine phosphatase SHP2 [11]. The interaction of
SHP2 results in its own tyrosine phosphorylation and
complex formation between SHP2 and GRB2. Thus, there
* Correspondence: dgfernig@liv.ac.uk
1 School of Biological Sciences, Biosciences Building, Crown Street, University 
of Liverpool, Liverpool, L69 7ZB, UK
Full list of author information is available at the end of the articleZhu et al. Cell Communication and Signaling 2010, 8:14
http://www.biosignaling.com/content/8/1/14
Page 2 of 10
are multiple routes for the recruitment of GRB2 to acti-
vated FGFR: to phosphorylated tyrosine residues of the
FGFR or to phosphorylated tyrosines on FRS2 and SHP2,
itself associated with FRS2. The importance of GRB2
recruitment is that it results in the activation of RAS and
the downstream activation of mitogen-activated protein
kinases (MAPK) p42 and p44. p42/44MAPK represent a
key pathway in cellular regulation by growth factors and
their kinetics of activation can determine cell fate [12].
There is considerable biological evidence to suggest
that the FGF receptor-ligand system is able to elicit differ-
ent signals, depending on the concentration of ligand and
the HS co-receptor. In cultured cells FGF ligands elicit a
biphasic growth response, such that they stimulate cell
proliferation at optimal concentrations, but fail to do so
at high concentration [13-15]. In vivo, gradients of FGF
ligands are a critical component of many developmental
events. For example, high and low concentrations of FGFs
pattern the ventral foregut into liver and lung [16] and a
focal source of FGF is required for limb outgrowth [17]. It
is also well established that the HS co-receptor modulates
the kinetics of activation of p42/44MAPK so that only in
the presence of the polysaccharide is the ligand-receptor
c o m p l e x  a b l e  t o  e l i c i t  s i g n a l s  t h a t  l e a d  t o  c e l l  d i v i s i o n
[18,19].
However, somewhat surprisingly, it is not known how
the HS co-receptor and concentration of FGF ligand may
elicit different signals and hence biological outcomes,
such as cell division and different cell fates in develop-
ment. We have, therefore, measured the phosphorylation
of both p42/44MAPK and the adaptor FRS-2 in cells lacking
the HS co-receptor and in cells treated with optimal (300
pg/mL) and high (≥ 100 ng/mL) concentrations of FGF-2.
The results indicate that only in the presence of the HS
co-receptor can the FGFR phosphorylate the adaptor
FRS-2 and so cause the sustained phosphorylation of
p42/44MAPK necessary for cells to enter the cell cycle.
Transient phosphorylation of p42/44MAPK can be inde-
pendent of the phosphorylation of FRS2 and occurs in the
absence of the HS co-receptor or at high concentrations
of FGF-2.
Results
FRS2 phosphorylation depends on HS
The stimulation of DNA synthesis by FGF-2 in rat mam-
mary (Rama) 27 fibroblasts depends on the FGFR activat-
ing a sustained dual phosphorylation of p42/44MAPK.
Thus, in chlorate-treated cells, which are HS-deficient,
FGF-2 alone only stimulates a transient dual phosphory-
lation of p42/44MAPK and fails to stimulate DNA synthe-
sis. The addition of heparin (a proxy for cellular HS)
restores the stimulation of DNA synthesis and the dual
phosphorylation of p42/44MAPK is sustained (Fig. 1), as we
have shown previously [18,19]. A key question is how
might the HS co-receptor influence the kinetics of phos-
phorylation of p42/44MAPK. Since the phosphorylation of
FRS-2 is a key early event in FGF signalling, this was mea-
sured. Interestingly, in cells rendered deficient in sulfated
HS by treatment with chlorate, stimulation by FGF-2
failed to cause the phosphorylation of FRS2. In contrast,
in the presence of heparin in the same chlorate-treated
cells, FRS2 phosphorylation was detected 5 min after the
addition of FGF-2 and its phosphorylation was sustained
to the end of the experiment (60 min, Fig. 2).
Dose response of FGF-2 stimulation of DNA synthesis and 
of dual phosphorylation of p42/44MAPK in Rama 27 
fibroblasts
Thus, the above data indicate that the HS co-receptor is
essential for the FGF-2 activated FGFR to phosphorylate
FRS-2, which is itself central to the sustained phosphory-
Figure 1 HS effect on the kinetics of dual phosphorylation of p42/
44 MAPK (A) DNA synthesis was determined in chlorate-treated quies-
cent serum-starved Rama 27 fibroblasts by the incorporation of [3H] 
thymidine into DNA 18 h after the addition of growth factor (see Meth-
ods), as follows: control, no addition, FGF, (0.3 ng/mL), heparin (10 ng/
mL). The results are the mean ± SD of triplicate wells of two experi-
ments. (B) Control or chlorate-treated quiescent Rama 27 fibroblasts 
were stimulated with 0.3 ng/mL FGF-2 (upper panel) or 0.3 ng/mL FGF-
2 and 10 ng/mL heparin (lower panel) for 0 min to 60 min and the dou-
bly phosphorylated Thr 183/202/Tyr 185/204 forms of p42/44MAPK (P-p42/
44MAPK) were detected with a monoclonal antibody (see Methods). The 
same blot was re-probed with anti-actin to show the level of loading 
of the gels.Zhu et al. Cell Communication and Signaling 2010, 8:14
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lation of p42/44MAPK. Intrigued by how changing the
extracellular composition of the signalling complex (FGF-
2 + HS + FGFR versus FGF + FGFR) determined whether
the adaptor FRS-2 was phosphorylated, we explored
another parameter that from a biological perspective
seemed likely to alter signalling, the concentration of
FGF-2 ligand. The stimulation of DNA synthesis in Rama
27 fibroblasts was determined over an extended range of
concentrations of FGF-2 (0.01 ng/mL to 300 ng/mL). As
previously shown in these cells [20], a stimulation of
DNA synthesis was first observed at 0.01 ng/mL FGF-2
and reached a maximum level at 0.3 ng/mL to 1 ng/mL
FGF-2 (Fig 3A). However, when the concentration of
FGF-2 was increased further, the level of stimulation of
DNA synthesis declined from this maximal level to reach
near basal levels at 300 ng/mL FGF-2 (Fig. 3A). As is
common in cell dose responses, some variation in the
downward curve was observed, which is reflected by the
magnitude of the residual stimulation of DNA synthesis
observed at 300 ng/mL FGF-2 (Fig. 3A, B). The low level
of stimulation of DNA synthesis at high concentrations of
F G F - 2  i s  l i k e l y  t o  be  d u e  t o  a  s pe c i f i c  c h a n g e  i n  F G F
receptor signalling, since when 3 ng/mL EGF was added
together with 300 ng/mL FGF-2, the level of DNA synthe-
sis was similar to that observed with EGF alone (Fig. 3B).
These results demonstrate that FGF-2 elicits a bell-
shaped dose response in Rama 27 fibroblasts, similar to
that observed by others in human umbilical endothelial
cells [13]. Importantly, high concentrations of FGF-2 do
not inhibit other growth factors from stimulating DNA
synthesis. We next examined the dual phosphorylation of
p42/44MAPK in Rama 27 fibroblasts in response to differ-
ent concentrations of FGF-2. Fifteen minutes after the
addition of the growth factor, a small increase in the dual
phosphorylation of p42/44MAPK  was observed in cells
stimulated with 0.01 ng/mL FGF-2 and this reached a
maximum at 0.3 ng/mL FGF-2 (Fig. 3C). At higher con-
centrations of the growth factor, the dual phosphoryla-
tion of p42/44MAPK declined from this maximal level such
that 100 ng/mL FGF-2 elicited the same low level of phos-
phorylation of p42/44MAPK as 0.01 ng/mL FGF-2. There-
fore, the concentration dependence of FGF-2 induced
p42/44MAPK phosphorylation (Fig. 3C) followed a similar
bell shape to that observed for DNA synthesis (Fig. 3A).
Kinetics of p42/44MAPK phosphorylation induced by 
different doses of FGF-2
One simple explanation for the decrease in p42/44MAPK
phosphorylation observed as the concentration of FGF-2
was increased from 0.3 ng/mL to 100 ng/mL was that
higher concentrations of growth factor would initiate
robust signalling earlier compared to lower concentra-
tions of FGF-2. These signals might also be inhibited ear-
lier by negative feedback loops. If this was the case, the
maximal p42/44MAPK  phosphorylation induced by the
highest concentration of FGF-2 should occur earlier and
more strongly than that found with lower concentrations
of the growth factor. To address this possibility, we inves-
tigated the kinetics of p42/44MAPK phosphorylation in
response to 0.01 ng/mL, 0.3 ng/mL and 100 ng/mL FGF-
2. Following the addition of 0.3 ng/mL FGF-2, the dual
phosphorylation of p42/44MAPK was detected within 3
min and reached a maximal level at 10 min. Subsequently,
30 min after the addition of FGF-2, the dual phosphoryla-
tion of p42/44MAPK decreased quite sharply to a lower
level, which was maintained to the end of experiment (Fig
4). The kinetics of p42/44MAPK phosphorylation following
the addition of 0.01 ng/mL FGF-2 showed a similar pat-
tern to that stimulated by 0.3 ng/mL. However, the onset
of the response was delayed and its amplitude was
weaker. Moreover, the plateau that followed the initial
peak in phosphorylation of p42/44MAPK declined gradu-
ally to nearly undetectable levels by the end of the experi-
ment (Fig. 4). These differences might be expected from a
submaximal stimulus, which is only effective at stimulat-
ing a minority of the cells into S-phase of the cell cycle
(Fig. 3A). In response to the addition of 100 ng/mL FGF-
2, the phosphorylation of p42/44MAPK was again apparent
at 3 min and reached a maximum at 5 min. However, the
level of phosphorylation of p42/44MAPK declined by 15
min and reached near basal levels at 30 min (Fig. 4).
Moreover, the amplitude of the early peak of p42/44MAPK
phosphorylation was reduced when cells were stimulated
with this high concentration of FGF-2 compared to cells
which were stimulated with 0.3 ng/mL FGF-2.
Effects of FGF-2 concentration on FRS2 phosphorylation
It was of interest to determine whether the different
kinetics of p42/44MAPK phosphorylation were associated
Figure 2 Effect of HS on FRS2 phosphorylation Control or chlorate-
treated quiescent Rama 27 fibroblasts were stimulated with either 0.3 
ng/mL FGF-2 (upper panel) or 0.3 ng/mL FGF2 and 10 ng/mL heparin 
(lower panel) for 0 min to 60 min. Following pull down with p13 suc1, 
phosphorylated FRS2 (P-FRS2) was identified by Western blotting (WB) 
with the phosphotyrosine antibody 4G10 (see Methods). The same 
blots were re-probed with anti-FRS2 to show the levels of loading of 
the gel.
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with differences in the phosphorylation of FRS-2. To this
end the phosphorylation of FRS2 was initially examined 5
min after stimulation of cells with different concentra-
tions of FGF-2. Consistent with the observed concentra-
tion-dependence of DNA synthesis and p42/44MAPK
phosphorylation, the maximum level of tyrosine phos-
phorylation of FRS2, detected as an immunoreactive
band of around 90 kDa with an antibody to phospho-
FRS2-α (Tyr196), also occurred at 0.3 ng/mL of FGF-2
(Fig 5). At 0.01 ng/mL and 100 ng/mL of FGF-2 a much
lower level of phosphorylation of FRS2 was observed,
which was only just above background (Fig. 5). This result
showed that phosphorylation of FRS2 was also dependent
on the concentration of FGF-2 and displayed a bell-
shaped dose-response curve.
It was important to measure the kinetics of phosphory-
lation of FRS2 to determine whether 100 ng/mL FGF-2
may elicit an earlier or a later peak of phosphorylation of
FRS2, compared to that occurring in the presence of 0.3
ng/mL FGF-2. In addition, since the phosphospecific
antibody only detects phosphorylation of one of several
tyrosines in FRS2, pull down with p13SUC1 followed by
immunoblotting with an antibody to phosphotyrosine
was used. In this way we could be certain that a lack of
signal was not due to a shift in the phosphorylation of
specific tyrosines in FRS2. Phosphorylation of FRS2 on
tyrosine was detected at 3 min after the addition of 0.3
ng/mL FGF-2 and reached a maximal level after 5 min.
The phosphorylation of FRS2 then declined rapidly at 10
min to reach a plateau at 15 min to 45 min, which was
sustained to the end of the experiment, 180 min (Fig. 6).
However, in response to 100 ng/mL FGF-2 only a very
low level of FRS2 phosphorylation was detected between
Figure 3 Dose-response of DNA synthesis and dual phosphorylation of p42/44 MAPK stimulated by FGF-2 Quiescent serum-starved Rama 27 
fibroblasts were stimulated with FGF-2 and EGF. (A, B) DNA synthesis was determined by the incorporation of [3H] thymidine into the DNA of quiescent 
Rama 27 fibroblasts 18 h after the addition of growth factor (see Methods) and results are the mean ± SD of triplicate wells of two experiments. (A) 
Dose response curve for FGF-2. (B) Stimulatory effect of 3 ng/mL EGF in the absence or presence of 300 ng/mL FGF-2. BSA is the negative control with 
no growth factor. (C) Dose-response of dual phosphorylation of p42/44 MAPK in quiescent Rama 27 fibroblasts stimulated with the indicated doses of 
FGF-2 for 15 min. The doubly phosphorylated Thr 183/202/Tyr 185/204 forms of p42/44 MAPK (P- p42/44 MAPK) were detected with a monoclonal antibody 
(see Methods). The same blot was re-probed with anti-actin to show the level of loading of the gel.
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3 min and 5 min and this level then declined by 10 min to
the basal levels observed in the unstimulated cells (Fig 6).
Discussion
A few studies carried out in the late 1980s evaluated the
activity of purified FGFs over a wide concentration range
and their results show that the stimulation of cell prolifer-
ation follows a bell-shaped dose response. Thus, cell pro-
liferation stimulated by FGF-2 in human umbilical vein
endothelial cells has a biphasic dose response, such that
supramaximal concentrations of the growth factor result
in submaximal to basal DNA synthesis [13]. Similar
results have been obtained with FGF-1 in Balb/c 3T3
fibroblasts [15] and in Rama 27 fibroblasts [14]. The pres-
ent results show that FGF-2 in Rama 27 fibroblasts also
elicits a bell-shaped dose response. It seems reasonable to
suggest that such bell-shaped dose response curves are a
general property of at least FGF-1 and FGF-2, if not all
FGFs. Importantly, the low to basal stimulation of DNA
synthesis at high concentrations of FGF-2 is intrinsic to
FGF-2, since EGF still stimulates DNA synthesis when
FGF-2 is also present at high concentration (Fig 3). It
should be noted that the above work uses S-phase entry
as a readout of the activity of the FGF. In vivo FGFs stimu-
late not just cell proliferation, but also cell survival, differ-
entiation, migration and metabolism [1]. Therefore, the
observed lack of cell proliferation observed at high con-
centrations of the growth factor does not mean that the
FGF is without biological effect in healthy tissue, as well
as in disease. Indeed, the biphasic response of cells to
FGF-1, FGF-2 and perhaps all FGFs has biological impli-
cations, which is reflected by experiments in vivo . Tis-
sues can contain high levels of FGFs. Thus, in the virgin
Figure 4 Kinetics of dual phosphorylation of p42/44 MAPK induced by different concentrations of FGF-2 Quiescent Rama 27 fibroblasts were 
stimulated with the indicated doses of FGF-2 for 0 min to 180 min. The doubly phosphorylated Thr 183/202/Tyr 185/204 forms of p42/44 MAPK (P- p42/44 
MAPK) were detected with a monoclonal antibody (see Methods). The blots were re-probed with anti-actin to show the level of loading of the gels.
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rat mammary gland there is 70 ng/g wet weight of
extractable FGF activity [21]. Concentration gradients of
FGFs are a key feature of organogenesis. For example, in
limb development the creation and maintenance of a con-
centration gradient of FGFs is crucial for the function of
the apical ectodermal ridge in promoting limb out-
growth, since only a focal concentration of FGFs can
replace the apical ectodermal ridge, whereas exposure of
the entire embryo to FGFs will not result in additional
limb development [17]. Similarly, high and low concen-
trations of FGFs pattern the ventral foregut into liver and
lung [16]. These in vivo observations indicate that the
FGFR should be able to elicit different intracellular sig-
nals, dependent on the concentration of FGF ligand.
To understand why FGF-2 at high concentrations fails
to stimulate DNA synthesis, two important signalling
events downstream of the FGFR were examined, the
phosphorylation of the adaptor FRS2 and of p42/44MAPK.
The phosphorylation of p42/44MAPK is the result of the
activation of the GRB2, RAS-RAF-MEK pathway and is
essential for the stimulation of DNA synthesis in these
cells. Recruitment of GRB2 can occur directly via the
FGFR or indirectly via the adaptor FRS2. At optimal con-
centrations for DNA synthesis, FGF-2 stimulated a sus-
tained phosphorylation of FRS2 and of p42/44MAPK. At
high concentrations of FGF-2, the adaptor protein FRS2
is only very weakly phosphorylated for a short time,
whereas the transient early phosphorylation of p42/
44MAPK was substantial. The transient very weak phos-
phorylation of FRS2 may be due simply to the time taken
for the ligand-receptor system to reach equilibrium with
the exogenous 100 ng/mL FGF-2. At 4°C it takes 60 min
to 90 min for the binding of exogenous FGF-2 to reach
equilibrium in these cells [20] and at 37°C equilibration
will be faster by about 6.5 fold, due to the increased ther-
mal energy. Thus, high concentrations of FGF-2 fail to
result in appreciable phosphorylation of FRS2, but still
stimulate a transient phosphorylation of p42/44MAPK,
which is likely to result from the recruitment of GRB2 to
the FGFR. These observations suggest that phosphoryla-
tion of FRS2 and consequent recruitment of GRB-2 via
FRS2 is essential for a sustained downstream phosphory-
lation of p42/44MAPK, whereas recruitment of GRB2
directly to the FGFR results only in a transient phospho-
rylation of p42/44MAPK.
Using a different approach with chlorate-treated, HS-
deficient cells, signalling assemblies lacking the HS co-
receptor and consisting of FGF2 ligand and FGFR were
Figure 6 Kinetics of FRS2 phosphorylation induced by different concentration of FGF-2 Rama 27 fibroblasts were stimulated with the indicated 
doses of FGF-2 for 0 min to 180 min. Following pull down with p13 suc1, phosphorylated FRS2 was identified by Western blotting (WB) with the phos-
photyrosine antibody 4G10 (see Methods). The same blots were re-probed with anti-FRS2 to show the levels of loading. Upper panel 0.3 ng/mL FGF-
2; lower panel 100 ng/mL FGF-2.
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examined. The results show that phosphorylation of
FRS2 again determines the kinetics of phosphorylation of
p42/44MAPK. In the absence of HS, there is no detectable
phosphorylation of FRS2, only a transient phosphoryla-
tion of p42/44MAPK is observed and DNA synthesis does
not occur.
Other work has indicated that FRS2 is central to the
FGFR eliciting a sustained phosphorylation of p42/
44MAPK. In cells expressing mutant FGFR-1, which cannot
bind GRB2 directly, since tyrosine residues lying outside
the activation loop that are normally phosphorylated are
mutated to phenylalanine, FGF-1 still stimulates phos-
phorylation of FRS2, activation of the GRB2-p42/44MAPK
pathway and cell proliferation [7]. This mutant receptor
can now only recruit GRB2 indirectly through FRS2 and
SHP2. In embryonic fibroblasts isolated from frs2 null
mice, FGF-1 can only cause the recruitment of GRB2
directly to the FGFR, which results in a transient phos-
phorylation of p42/44MAPK and no stimulation of cell pro-
liferation; re-expression of FRS2 in the frs2  null cells
restores the ability of FGF-1 to stimulate a sustained
phosphorylation of p42/44MAPK  and cell proliferation
[22].
An important question is how might changes in FGF-2
concentration or the absence of HS co-receptor cause the
altered phosphorylation kinetics of FRS2 and p42/44MAPK
and so change the biological outcome of FGF signaling. In
the case of the HS co-receptor, it is now established that
FGF ligands can engage the FGFR independently of the
polysaccharide [23]. Thus, one explanation for the pres-
ent results is that only in the presence of HS can FGF-2
cause the assembly of a FGFR complex that is capable of
phosphorylating FRS2.
In the case of the concentration of FGF ligand, the most
likely explanations are either changes in negative feed-
back loops that depend on ligand concentration or differ-
ences in the type of receptor complex that is assembled.
Negative feedback that could be increased at high con-
centrations of FGF-2 includes dephosphorylation and
receptor down-regulation. Although neither can be for-
mally excluded, three lines of evidence suggest that nega-
tive feedback may be a contributory, but not a dominant
mechanism: the lack of phosphorylation of FRS2 at high
concentrations of FGF-2, which is observed at times too
short for receptor down-regulation; the differences in
timing of the first peak of p42/44MAPK phosphorylation
correlates with concentration and in all likelihood reflects
increased on-rates of FGF-2 ligand; the reduced ampli-
tude of the first peak of p42/44MAPK phosphorylation
observed with high, compared to optimal concentrations
of FGF-2.
The assembly of the FGF receptor ligand system could
change due to the concentration of FGF-2, particularly
since there is evidence for FGF-2 possessing two binding
sites for the FGFR of different affinities [24] and three
binding sites for the HS co-receptor, which are also likely
to be of different affinity [25]. Consequently, interactions
of FGF-2 with HS or the FGFR that may be of high stoi-
chiometry, e.g., 1FGF:2FGFR, at low concentrations of
FGF-2, would be of lower order stoichiometry, e.g.,
1FGF:1FGFR, at the high concentration of the growth
factor used here; 300 pg/mL or 16 pM is around the K D of
the high affinity binding site on these cells, whereas 100
ng/mL or 5.6 nM is more than two orders of magnitude
higher [20]. This may enable the secondary binding sites
on the FGF-2 ligand to engage their partner(s) indepen-
dently of the primary binding site. The observation that
FRS2 is only phosphorylated at lower concentrations of
FGF-2 indicates that this event may depend, in turn, on
an extracellular interaction of the FGF-2 that has a high
stoichiometry. Given that biophysical and structural anal-
yses have produced competing views of the assembly of
the FGF ligand-receptor complex [24,26-30], it may be
that more than one of these is physiologically relevant,
depending on the conditions. However, such in vitro
analyses do not account for the complexity of interactions
at the cell surface. For example, there is good evidence for
neuropilin [31], anosmin-1 [32], cell adhesion molecules
such as L1 and cadherins [33-36] and integrins [37] not
only binding directly to one or more of the components
of the FGF-receptor complex, but also modulating the
activity of the FGFR. Thus, there remains a substantial
challenge in defining the FGF receptor-ligand com-
plex(es) that are formed on living cells and responsible for
the different types of signalling observed in the present
work.
Conclusions
The results show that the concentration of FGF ligand
and the presence of HS co-receptor determine whether
the FGFR phosphorylates the adaptor FRS2. This deter-
mines the kinetics of phosphorylation of p42/44MAPK,
which in turn decides whether FGF signaling stimulates
cell proliferation or a different response. These data dem-
onstrate that the FGF receptor ligand system is capable of
generating distinct signal outputs due to parameters (HS
and FGF ligand concentration) that are known to deter-
mine FGF signaling in development and may be impor-
tant in disease. Therefore the results demonstrate that
these parameters can switch FGF signaling between a
proliferative and a non-proliferative response and this
would then enable the FGFR to interpret FGF gradients inZhu et al. Cell Communication and Signaling 2010, 8:14
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development [16,17] and differences in HS struc-
tures[38].
Methods
Materials
Human recombinant FGF-2 was obtained from R & D
Systems (Abingdon, Oxon, UK) and mouse epidermal
growth factor (EGF) was obtained from Pepsyn (Liver-
pool, UK). Cell culture reagents were from Life Technolo-
gies (Paisley, UK). Reagents for SDS-PAGE and
electrotransfer were purchased from Bio-Rad (Hemel
Hempstead, Herts, UK). Protease inhibitor mixture was
from Roche Molecular Biochemicals (Lewes, UK). Anti-
body to phosphotyrosine (4G10) and P13suc1 agarose were
from UpState Biotechnologies (Milton Keynes, UK).
Anti-FRS2 was from Santa Cruz Biotechnology (Heidel-
berg, Germany). Anti- p42/44MAPK, anti-phospho-p44/
42MAPK  (Thr183/202/Tyr185/204) (E10) and anti-
phosphoFRS2-α (Tyr 196) were from Cell Signalling
Technology (Hitchin, UK). Anti-actin was from Sigma-
Aldrich Co. Secondary peroxidase-labelled anti-IgG anti-
bodies (anti-rabbit and anti-mouse) were from Amer-
sham Bioscience (Little Chalfont, Bucks., UK).
Cell Culture and DNA Synthesis
Rama 27 fibroblasts were cultured in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 5% (v/v)
fetal calf serum, 50 ng/mL insulin and 50 ng/mL hydro-
cortisone [39]. Chlorate was used to inhibit sulfation of
glycosaminoglycans, by virtue of its inhibition of the syn-
thesis of PAPS (3'-phosphoadenosine 5'-phosphosulfate),
the activated sulfate donor [40-42]. Sulfated glycosamino-
glycan-deficient Rama 27 cells were prepared as
described [43]. Concisely, cells were incubated for 4 h in
sulfate-free Dulbecco's modified Eagle's medium, supple-
mented with 10% (v/v) dialyzed fetal calf serum and 15
mM NaClO 3. Following trypsinisation, the cells were
seeded in plates as appropriate for the measurement
(DNA synthesis, Western blotting, pull down), except
that sulfate-free Dulbecco's modified Eagle's medium
supplemented with 15 mM NaClO 3 was used through-
out.
DNA synthesis assays were performed as described
previously [18,19]. Rama 27 fibroblasts, seeded in 24-well
plates at a density of 15000 cells/well were rendered qui-
escent by 24 h incubation in 500 μL serum-free DMEM
containing 250 μg/mL bovine serum albumin (step down
medium-SDM). The medium was replaced with fresh
SDM 6 h before the addition of growth factors. Twenty
μL of 40 μCi/mL [methyl- 3H] thymidine (ICN, Basing-
stoke, UK) was added directly to the culture medium 18 h
later for 1 h and radioactivity in DNA, precipitated with
5% (w/v) trichloroacetic acid, was measured by liquid
scintillation counting.
P13suc1 Pull Down
FRS2 binds the cyclin-dependent kinase substrate p13suc1
[44], which provides a convenient means to extract FRS2
from cell lysates. Rama 27 fibroblasts were seeded at
20,000 cells/cm2 in 9 cm diameter culture dishes (1.3 ×
106 cells in 10 mL medium per dish) and then treated as
for the DNA synthesis assay up to the addition of growth
factors. At the times indicated, Rama 27 cells were
washed twice with ice-cold Tris-buffered saline (TBS)
contained 100 μM sodium vanadate and then lysed in 500
μL lysis buffer (20 mM Tris-HCl, 137 mM NaCl, 10% (v/
v) glycerol, 1% (v/v) NP-40, 1 mM sodium vanadate,
pH7.0) with one tablet of protease inhibitor mixture
(Roche, Lewes, UK) per 10 mL. Culture dishes were gen-
tly rocked for 20 min at 4°C after addition of lysis buffer.
Adherent material was then detached by scraping and the
lysates were transferred to pre-cooled microcentrifuge
tubes. Culture dishes were washed once with 200 μL of
lysis buffer, which was combined with the lysate. Lysates
were clarified by centrifugation at 12000 g for 10 min.
The supernatants were then transferred to fresh micro-
centrifuge tubes containing 40 μL lysis buffer and p13suc1
agarose suspension (3:1 v/v) and the slurry was incubated
at 4°C on a rocker platform overnight. Agarose beads
were collected by centrifugation at 12000 g for 5 min and
washed by centrifugation three times with lysis buffer and
once with water. Following resuspension of the final pel-
let in 60 μL electrophoresis sample buffer (250 mM Tris-
HCl, 1% (w/v) SDS, 0.006% (w/v) bromophenol blue, 2%
(v/v), β-mercaptoethanol, pH 6.8) with one tablet of pro-
tease inhibitor mixture per 10 mL, samples were boiled
for 5 min.
Identification of MAPK and FRS2 phosphorylation
Rama 27 fibroblasts were cultured exactly as for p13suc1
pull-down experiments. At the times indicated, Rama 27
cells were washed twice with ice-cold PBS and collected
by scraping in 300 μL of 2× electrophoresis sample buffer
and then boiled for 5 min.
SDS-PAGE and Western Blotting
Polypeptides in samples containing identical amounts of
protein were separated by electrophoresis on appropriate
polyacrylamide gels in the presence of SDS and trans-
ferred to nitrocellulose membranes. Following blocking
with TBS containing 0.05% (v/v) Tween 20 (TBS-Tween)
and 5% (w/v) non-fat dry milk (blocking buffer) for 1 h,
membranes were probed with appropriate primary anti-
bodies overnight with gentle shaking at 4°C. After three
washes with TBS-Tween, the membranes were incubated
with the corresponding secondary peroxidase-conjugated
polyclonal antibodies in blocking buffer for 1 h, washed
three times in TBS-Tween, and bound peroxidase was
detected with the SuperSignal chemiluminescent systemZhu et al. Cell Communication and Signaling 2010, 8:14
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(Pierce and Warriner, Chester, UK) on Hyperfilm (Amer-
sham Pharmacia Biotech). Activated p42/44MAPK  was
detected using a monoclonal antibody directed against
the doubly phosphorylated Thr183/202Tyr185/204 forms of
these enzymes. This antibody does not cross-react,
according to the manufacturer, with the corresponding
doubly phosphorylated SAPK/JNK, p38 MAPKs or
monophosphorylated p42/44MAPK. The phosphorylation
of FRS2 was detected using anti-phosphotyrosine 4G10
following P13suc1 pulling down or by a polyclonal anti-
body directed against the phosphorylated FRS2-α
(Tyr196). This antibody does not cross-react with unre-
lated tyrosine-phosphorylated proteins and it produced
results equivalent to the pull down followed by Western
blotting with 4G10. Where appropriate, the same mem-
brane was re-probed with anti-actin or anti-FRS2 to show
the level of loading. Each Western blot is one of at least
three independent experiments.
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